作者:
White,D.L. [1]
;
Radich,J. [2]
;
Soverini,S. [3]
;
Saunders,V.A. [4]
;
Frede,A.K. [5]
;
Dang,P. [6]
;
Cilloni,D. [7]
;
Lin,P. [8]
;
Mongay,L. [9]
;
Woodman,R. [10]
;
Manley,P. ;
Slader,C. ;
Kim,D.W. ;
Pane,F. ;
Martinelli,G. ;
Saglio,G. ;
Hughes,T.P.
作者单位:
Catholic University of Korea, Seoul St Mary's Hospital, Seoul, South Korea
[1]
Novartis Oncology, Florham Park, NJ, United States
[2]
Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy
[3]
Department of Haematology/Oncology 'L. e A. Seràgnoli', University of Bologna, Italy
[4]
Department of Haematology, SA Pathology(IMVS site) and CCB, RAH Campus, PO Box 14 Rundle Mall Post
[5]
Novartis Oncology, Sydney, Australia
[6]
Department of Biology, University of Bologna, Bologna, Italy
[7]
Novartis Pharmaceuticals, Basel, Switzerland
[8]
Division of Haematology, University of Naples 'Federico II', Naples, Italy
[9]
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
[10]
发布时间
2013-11-20